mr BRIAN TOOHEY

H.R. 628, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges: establishing a pilot program for district court judges concerning patent litigation H.R. 1260, Patent Reform Act of 2009: reforms of the patent laws H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics H.R. 1548, Pathway for Biosimilars Act, House: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics H.R. 1706, Protecting Consumer Access to Generic Drugs Act of 2009: patent settlements S. 299, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges: establishing a pilot program for district court judges concerning patent litigation S. 369, Preserve Access to Affordable Generics Act: patent settlements S. 515, Patent Reform Act of 2009: reforms of the patent laws S. 560, Patent Reform Act of 2009: reforms of the patent laws S. 610, Patent Reform Act of 2009: reforms of the patent laws S. 726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics International intellectual property issues

H.R. 1, American Recovery and Reinvestment Act of 2009: trade adjustment assistance issues S. 1, American Recovery and Reinvestment Act of 2009: trade adjustment assistance issues S. 336, American Recovery and Reinvestment Act of 2009: trade adjustment assistance issues Korea Free Trade Agreement: intellectual property, market access and public health Peru Free Trade Agreement: intellectual property, market access and public health International market access and intellectual property issues Trade enforcement issues

H.R. 628, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges: establishing a pilot program for district court judges concerning patent litigation H.R. 1260, Patent Reform Act of 2009: reforms of the patent laws H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics H.R. 1548, Pathway for Biosimilars Act, House: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics H.R. 1706, Protecting Consumer Access to Generic Drugs Act of 2009: patent settlements S. 299, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges: establishing a pilot program for district court judges concerning patent litigation S. 369, Preserve Access to Affordable Generics Act: patent settlements S. 515, Patent Reform Act of 2009: reforms of the patent laws S. 560, Patent Reform Act of 2009: reforms of the patent laws S. 610, Patent Reform Act of 2009: reforms of the patent laws S. 726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics International intellectual property issues

H.R. 1, American Recovery and Reinvestment Act of 2009: trade adjustment assistance issues S. 1, American Recovery and Reinvestment Act of 2009: trade adjustment assistance issues S. 336, American Recovery and Reinvestment Act of 2009: trade adjustment assistance issues Korea Free Trade Agreement: intellectual property, market access and public health Peru Free Trade Agreement: intellectual property, market access and public health International market access and intellectual property issues Trade enforcement issues

H.R. 628, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges: establishing a pilot program for district court judges concerning patent litigation H.R. 1260, Patent Reform Act of 2009: reforms of the patent laws H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics H.R. 1548, Pathway for Biosimilars Act, House: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics H.R. 1706, Protecting Consumer Access to Generic Drugs Act of 2009: patent settlements S. 299, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges: establishing a pilot program for district court judges concerning patent litigation S. 369, Preserve Access to Affordable Generics Act: patent settlements S. 515, Patent Reform Act of 2009: reforms of the patent laws S. 560, Patent Reform Act of 2009: reforms of the patent laws S. 610, Patent Reform Act of 2009: reforms of the patent laws S. 726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics International intellectual property issues

H.R. 628, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges: establishing a pilot program for district court judges concerning patent litigation H.R. 1260, Patent Reform Act of 2009: reforms of the patent laws H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics H.R. 1548, Pathway for Biosimilars Act, House: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics H.R. 1706, Protecting Consumer Access to Generic Drugs Act of 2009: patent settlements S. 299, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges: establishing a pilot program for district court judges concerning patent litigation S. 369, Preserve Access to Affordable Generics Act: patent settlements S. 515, Patent Reform Act of 2009: reforms of the patent laws S. 560, Patent Reform Act of 2009: reforms of the patent laws S. 610, Patent Reform Act of 2009: reforms of the patent laws S. 726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics International intellectual property issues

H.R. 628, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges: establishing a pilot program for district court judges concerning patent litigation H.R. 1260, Patent Reform Act of 2009: reforms of the patent laws H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics H.R. 1548, Pathway for Biosimilars Act, House: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics H.R. 1706, Protecting Consumer Access to Generic Drugs Act of 2009: patent settlements S. 299, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges: establishing a pilot program for district court judges concerning patent litigation S. 369, Preserve Access to Affordable Generics Act: patent settlements S. 515, Patent Reform Act of 2009: reforms of the patent laws S. 560, Patent Reform Act of 2009: reforms of the patent laws S. 610, Patent Reform Act of 2009: reforms of the patent laws S. 726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics International intellectual property issues

H.R. 628, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges: establishing a pilot program for district court judges concerning patent litigation H.R. 1260, Patent Reform Act of 2009: reforms of the patent laws H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics H.R. 1548, Pathway for Biosimilars Act, House: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics H.R. 1706, Protecting Consumer Access to Generic Drugs Act of 2009: patent settlements S. 299, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges: establishing a pilot program for district court judges concerning patent litigation S. 369, Preserve Access to Affordable Generics Act: patent settlements S. 515, Patent Reform Act of 2009: reforms of the patent laws S. 560, Patent Reform Act of 2009: reforms of the patent laws S. 610, Patent Reform Act of 2009: reforms of the patent laws S. 726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics International intellectual property issues

H.R. 628, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges: establishing a pilot program for district court judges concerning patent litigation H.R. 1260, Patent Reform Act of 2009: reforms of the patent laws H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics H.R. 1548, Pathway for Biosimilars Act, House: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics H.R. 1706, Protecting Consumer Access to Generic Drugs Act of 2009: patent settlements S. 299, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges: establishing a pilot program for district court judges concerning patent litigation S. 369, Preserve Access to Affordable Generics Act: patent settlements S. 515, Patent Reform Act of 2009: reforms of the patent laws S. 560, Patent Reform Act of 2009: reforms of the patent laws S. 610, Patent Reform Act of 2009: reforms of the patent laws S. 726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics International intellectual property issues

H.R. 380, Pharmaceutical Market Access and Drug Safety Act of 2007: importation H.R. 1038, Access to Life-Saving Medicine Act: follow-on biologics H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007: follow-on biologics H.R. 3610, Food and Drug Import Safety Act of 2007: import safety H.R. 5629, Pathway for Biosimilars Act: follow-on biologics H.R. 5839, Safeguarding America's Pharmaceuticals Act of 2008: anti-counterfeiting H.R. 6151, Responsibility in Drug and Device Advertising Act of 2008: Direct-to-consumer drug advertising H.R. 6381, Medical Device Safety Act of 2008: preemption issues H.R. 6820, Water Assessment and Treatment Evaluation Research Study Act of 2008: pharmaceuticals in drinking water and human health S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007: importation S. 334, Healthy Americans Act: non-interference S. 623, Access to Life-Saving Medicine Act: follow-on biologics S. 1693, Wired for Health Care Quality Act: health information technology and health care quality and costs S. 1695, Biologics Price Competition and Innovation Act of 2007: follow-on biologics S. 2663, CPSC Reform Act: importation S. 3046, Access, Compassion, Care, and Ethics for Seriously Ill Patients Act (ACCESS Act): access to investigational drugs and related issues S. 3398, Medical Device Safety Act of 2008: preemption issues S. 3409, Drug and Device Accountability Act of 2008: import safety S. 3560, QI Program Supplemental Funding Act of 2008: antibiotic exclusivity provisions S. 3633, Transparency in Drug Labeling Act: country of origin labeling for drugs

H.R. 1902, Protecting Consumer Access to Generic Drugs Act of 2007: patent settlements H.R. 1908, Patent Reform Act of 2007: patent issues S. 1145, Patent Reform Act of 2007: patent issues S. 316, Preserve Access to Affordable Generics Act: patent settlements Preparation for Senate reauthorization of the Federal Trade Commission (no bill introduced yet) International intellectual property issues

H.R. 1902, Protecting Consumer Access to Generic Drugs Act of 2007: patent settlements H.R. 1908, Patent Reform Act of 2007: patent issues H.R. 4279, Prioritizing Resources and Organization for Intellectual Property Act of 2007: enforcement S. 316, Preserve Access to Affordable Generics Act: patent settlements S. 522, Intellectual Property Rights Enforcement Act: anti-counterfeiting and enforcement S. 1145, Patent Reform Act of 2007: patent issues S. 2317, Intellectual Property Enforcement Act of 2007: enforcement Senate reauthorization of the Federal Trade Commission (no bill introduced during reporting period) International intellectual property issues

H.R. 1902, Protecting Consumer Access to Generic Drugs Act of 2007: patent settlements H.R. 1908, Patent Reform Act of 2007: patent system reform and related issues such as obtaining/opposing patents and remedies H.R. 4279, Prioritizing Resources and Organization for Intellectual Property Act of 2007: enforcement S. 316, Preserve Access to Affordable Generics Act: patent settlements S. 522, Intellectual Property Rights Enforcement Act: anti-counterfeiting and enforcement S. 1145, Patent Reform Act of 2007: patent system reform and related issues such as obtaining/opposing patents and remedies S. 2317, Intellectual Property Enforcement Act of 2007: enforcement S. 3325, Prioritizing Resources and Organization for Intellectual Property Act of 2008: enforcement S. 3464, International Intellectual Property Protection and Enforcement Act of 2008: enforcement S. 3600, Patent Reform Act of 2008: patent system reform and related issues such as obtaining/opposing patents and remedies International intellectual property issues

H.R. 1902, Protecting Consumer Access to Generic Drugs Act of 2007: patent settlements H.R. 1908, Patent Reform Act of 2007: patent issues H.R. 4279, Prioritizing Resources and Organization for Intellectual Property Act of 2007: enforcement S. 316, Preserve Access to Affordable Generics Act: patent settlements S. 522, Intellectual Property Rights Enforcement Act: anti-counterfeiting and enforcement S. 1145, Patent Reform Act of 2007: patent issues S.2317, Intellectual Property Enforcement Act of 2007: enforcement S.3325, Prioritizing Resources and Organization for Intellectual Property Act of 2008: enforcement S.3600, Patent Reform Act of 2008: patent reform and related issues International intellectual property issues

H.R. 1902, Protecting Consumer Access to Generic Drugs Act of 2007: patent settlements H.R. 1908, Patent Reform Act of 2007: patent system reform and related issues such as obtaining/opposing patents and remedies H.R. 4279, Prioritizing Resources and Organization for Intellectual Property Act of 2007: enforcement S. 316, Preserve Access to Affordable Generics Act: patent settlements S. 522, Intellectual Property Rights Enforcement Act: anti-counterfeiting and enforcement S. 1145, Patent Reform Act of 2007: patent system reform and related issues such as obtaining/opposing patents and remedies S. 2317, Intellectual Property Enforcement Act of 2007: enforcement S. 3325, Prioritizing Resources and Organization for Intellectual Property Act of 2008: enforcement S. 3464, International Intellectual Property Protection and Enforcement Act of 2008: enforcement S. 3600, Patent Reform Act of 2008: patent system reform and related issues such as obtaining/opposing patents and remedies International intellectual property issues

H.R. 1902, Protecting Consumer Access to Generic Drugs Act of 2007: patent settlements H.R. 1908, Patent Reform Act of 2007: patent issues H.R. 4279, Prioritizing Resources and Organization for Intellectual Property Act of 2007: enforcement S. 316, Preserve Access to Affordable Generics Act: patent settlements S. 522, Intellectual Property Rights Enforcement Act: anti-counterfeiting and enforcement S. 1145, Patent Reform Act of 2007: patent issues S.2317, Intellectual Property Enforcement Act of 2007: enforcement S.3325, Prioritizing Resources and Organization for Intellectual Property Act of 2008: enforcement S.3600, Patent Reform Act of 2008: patent reform and related issues International intellectual property issues

H.R. 1902, Protecting Consumer Access to Generic Drugs Act of 2007: patent settlements H.R. 1908, Patent Reform Act of 2007: patent issues S. 1145, Patent Reform Act of 2007: patent issues S. 316, Preserve Access to Affordable Generics Act: patent settlements Preparation for Senate reauthorization of the Federal Trade Commission (no bill introduced yet) International intellectual property issues

H.R. 1902, Protecting Consumer Access to Generic Drugs Act of 2007: patent settlements H.R. 1908, Patent Reform Act of 2007: patent issues H.R. 4279, Prioritizing Resources and Organization for Intellectual Property Act of 2007: enforcement S. 316, Preserve Access to Affordable Generics Act: patent settlements S. 522, Intellectual Property Rights Enforcement Act: anti-counterfeiting and enforcement S. 1145, Patent Reform Act of 2007: patent issues S. 2317, Intellectual Property Enforcement Act of 2007: enforcement Senate reauthorization of the Federal Trade Commission (no bill introduced during reporting period) International intellectual property issues

H.R. 380, Pharmaceutical Market Access and Drug Safety Act of 2007: importation H.R. 1038, Access to Life-Saving Medicine Act: follow-on biologics H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007: follow-on biologics H.R. 3610, Food and Drug Import Safety Act of 2007: import safety H.R. 5629, Pathway for Biosimilars Act: follow-on biologics H.R. 5839, Safeguarding America's Pharmaceuticals Act of 2008: anti-counterfeiting H.R. 6151, Responsibility in Drug and Device Advertising Act of 2008: Direct-to-consumer drug advertising H.R. 6381, Medical Device Safety Act of 2008: preemption issues H.R. 6820, Water Assessment and Treatment Evaluation Research Study Act of 2008: pharmaceuticals in drinking water and human health S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007: importation S. 334, Healthy Americans Act: non-interference S. 623, Access to Life-Saving Medicine Act: follow-on biologics S. 1693, Wired for Health Care Quality Act: health information technology and health care quality and costs S. 1695, Biologics Price Competition and Innovation Act of 2007: follow-on biologics S. 2663, CPSC Reform Act: importation S. 3046, Access, Compassion, Care, and Ethics for Seriously Ill Patients Act (ACCESS Act): access to investigational drugs and related issues S. 3398, Medical Device Safety Act of 2008: preemption issues S. 3409, Drug and Device Accountability Act of 2008: import safety S. 3560, QI Program Supplemental Funding Act of 2008: antibiotic exclusivity provisions S. 3633, Transparency in Drug Labeling Act: country of origin labeling for drugs

H.R. 380, Pharmaceutical Market Access and Drug Safety Act of 2007: importation H.R. 1038, Access to Life-Saving Medicine Act: follow-on biologics H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007: follow-on biologics H.R. 3610, Food and Drug Import Safety Act of 2007: import safety H.R. 5629, Pathway for Biosimilars Act: follow-on biologics H.R. 5839, Safeguarding America's Pharmaceuticals Act of 2008: anti-counterfeiting H.R. 6151, Responsibility in Drug and Device Advertising Act of 2008: Direct-to-consumer drug advertising H.R. 6381, Medical Device Safety Act of 2008: preemption issues H.R. 6820, Water Assessment and Treatment Evaluation Research Study Act of 2008: pharmaceuticals in drinking water and human health S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007: importation S. 334, Healthy Americans Act: non-interference S. 623, Access to Life-Saving Medicine Act: follow-on biologics S. 1693, Wired for Health Care Quality Act: health information technology and health care quality and costs S. 1695, Biologics Price Competition and Innovation Act of 2007: follow-on biologics S. 2663, CPSC Reform Act: importation S. 3046, Access, Compassion, Care, and Ethics for Seriously Ill Patients Act (ACCESS Act): access to investigational drugs and related issues S. 3398, Medical Device Safety Act of 2008: preemption issues S. 3409, Drug and Device Accountability Act of 2008: import safety S. 3560, QI Program Supplemental Funding Act of 2008: antibiotic exclusivity provisions S. 3633, Transparency in Drug Labeling Act: country of origin labeling for drugs

H.R. 380, Pharmaceutical Market Access and Drug Safety Act of 2007: importation H.R. 1038, Access to Life-Saving Medicine Act: follow-on biologics H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007: follow-on biologics H.R. 3610, Food and Drug Import Safety Act of 2007: import safety H.R. 5629, Pathway for Biosimilars Act: follow-on biologics H.R. 5839, Safeguarding America's Pharmaceuticals Act of 2008: anti-counterfeiting H.R. 6151, Responsibility in Drug and Device Advertising Act of 2008: Direct-to-consumer drug advertising H.R. 6381, Medical Device Safety Act of 2008: preemption issues H.R. 6820, Water Assessment and Treatment Evaluation Research Study Act of 2008: pharmaceuticals in drinking water and human health S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007: importation S. 334, Healthy Americans Act: non-interference S. 623, Access to Life-Saving Medicine Act: follow-on biologics S. 1693, Wired for Health Care Quality Act: health information technology and health care quality and costs S. 1695, Biologics Price Competition and Innovation Act of 2007: follow-on biologics S. 2663, CPSC Reform Act: importation S. 3046, Access, Compassion, Care, and Ethics for Seriously Ill Patients Act (ACCESS Act): access to investigational drugs and related issues S. 3398, Medical Device Safety Act of 2008: preemption issues S. 3409, Drug and Device Accountability Act of 2008: import safety S. 3560, QI Program Supplemental Funding Act of 2008: antibiotic exclusivity provisions S. 3633, Transparency in Drug Labeling Act: country of origin labeling for drugs

H.R. 3920, Trade and Globalization Assistance Act of 2007: trade adjustment assistance issues H.R. 6180, Trade Reform, Accountability, Development, and Employment Act of 2008 (TRADE Act of 2008): intellectual property S. 1848, Trade and Globalization Adjustment Assistance Act of 2007: trade adjustment assistance issues S.3083, Trade Reform, Accountability, Development, and Employment Act of 2008 (TRADE Act of 2008): intellectual property Colombia Free Trade Agreement: intellectual property, market access and public health Korea Free Trade Agreement: intellectual property, market access and public health Implementation of Peru Free Trade Agreement: intellectual property, market access and public health International market access and intellectual property issues

H.R. 3920, Trade and Globalization Assistance Act of 2007: trade adjustment assistance issues H.R. 5501, President's Emergency Plan For AIDS Relief (PEPFAR): intellectual property, access to medicines and public health H.R. 6180, Trade Reform, Accountability, Development, and Employment Act of 2008 (TRADE Act of 2008): intellectual property S. 1848, Trade and Globalization Adjustment Assistance Act of 2007: trade adjustment assistance issues S. 2731, President's Emergency Plan For AIDS Relief (PEPFAR): intellectual property, access to medicines and public health S. 3083, Trade Reform, Accountability, Development, and Employment Act of 2008 (TRADE Act of 2008): intellectual property Colombia Free Trade Agreement: intellectual property, market access and public health Korea Free Trade Agreement: intellectual property, market access and public health Implementation of Peru Free Trade Agreement: intellectual property, market access and public health World Health Organization (WHO) Intergovernmental Working Group on Public Health, Innovation and Intellectual Property (IGWG): intellectual property, access and public health World Trade Organization (WTO) intellectual property enforcement issues International market access and intellectual property issues

H.R. 3920, Trade and Globalization Assistance Act of 2007: trade adjustment assistance issues H.R. 5501, President's Emergency Plan For AIDS Relief (PEPFAR): intellectual property, access to medicines and public health S. 1848, Trade and Globalization Adjustment Assistance Act of 2007: trade adjustment assistance issues S.2731, President's Emergency Plan For AIDS Relief (PEPFAR): intellectual property, access to medicines and public health Colombia Free Trade Agreement: intellectual property, market access and public health Korea Free Trade Agreement: intellectual property, market access and public health Implementation of Peru Free Trade Agreement: intellectual property, market access and public health World Health Organization (WHO) Intergovernmental Working Group on Public Health, Innovation and Intellectual Property (IGWG): intellectual property, access and public health International market access and intellectual property issues

H.R. 3920, Trade and Globalization Assistance Act of 2007: trade adjustment assistance issues H.R. 5501, President's Emergency Plan For AIDS Relief (PEPFAR): intellectual property, access to medicines and public health H.R. 6180, Trade Reform, Accountability, Development, and Employment Act of 2008 (TRADE Act of 2008): intellectual property S. 1848, Trade and Globalization Adjustment Assistance Act of 2007: trade adjustment assistance issues S.2731, President's Emergency Plan For AIDS Relief (PEPFAR): intellectual property, access to medicines and public health S.3083, Trade Reform, Accountability, Development, and Employment Act of 2008 (TRADE Act of 2008): intellectual property Colombia Free Trade Agreement: intellectual property, market access and public health Korea Free Trade Agreement: intellectual property, market access and public health Implementation of Peru Free Trade Agreement: intellectual property, market access and public health World Trade Organization intellectual property enforcement issues International market access and intellectual property issues

H.R. 1902, Protecting Consumer Access to Generic Drugs Act of 2007: patent settlements H.R. 1908, Patent Reform Act of 2007: patent system reform and related issues such as obtaining/opposing patents and remedies H.R. 4279, Prioritizing Resources and Organization for Intellectual Property Act of 2007: enforcement S. 316, Preserve Access to Affordable Generics Act: patent settlements S. 522, Intellectual Property Rights Enforcement Act: anti-counterfeiting and enforcement S. 1145, Patent Reform Act of 2007: patent system reform and related issues such as obtaining/opposing patents and remedies S. 2317, Intellectual Property Enforcement Act of 2007: enforcement S. 3325, Prioritizing Resources and Organization for Intellectual Property Act of 2008: enforcement S. 3464, International Intellectual Property Protection and Enforcement Act of 2008: enforcement S. 3600, Patent Reform Act of 2008: patent system reform and related issues such as obtaining/opposing patents and remedies International intellectual property issues

H.R. 1902, Protecting Consumer Access to Generic Drugs Act of 2007: patent settlements H.R. 1908, Patent Reform Act of 2007: patent issues H.R. 4279, Prioritizing Resources and Organization for Intellectual Property Act of 2007: enforcement S. 316, Preserve Access to Affordable Generics Act: patent settlements S. 522, Intellectual Property Rights Enforcement Act: anti-counterfeiting and enforcement S. 1145, Patent Reform Act of 2007: patent issues S.2317, Intellectual Property Enforcement Act of 2007: enforcement S.3325, Prioritizing Resources and Organization for Intellectual Property Act of 2008: enforcement S.3600, Patent Reform Act of 2008: patent reform and related issues International intellectual property issues

H.R. 1902, Protecting Consumer Access to Generic Drugs Act of 2007: patent settlements H.R. 1908, Patent Reform Act of 2007: patent issues H.R. 4279, Prioritizing Resources and Organization for Intellectual Property Act of 2007: enforcement S. 316, Preserve Access to Affordable Generics Act: patent settlements S. 522, Intellectual Property Rights Enforcement Act: anti-counterfeiting and enforcement S. 1145, Patent Reform Act of 2007: patent issues S. 2317, Intellectual Property Enforcement Act of 2007: enforcement Senate reauthorization of the Federal Trade Commission (no bill introduced during reporting period) International intellectual property issues

H.R. 3920, Trade and Globalization Assistance Act of 2007: trade adjustment assistance issues H.R. 5501, President's Emergency Plan For AIDS Relief (PEPFAR): intellectual property, access to medicines and public health H.R. 6180, Trade Reform, Accountability, Development, and Employment Act of 2008 (TRADE Act of 2008): intellectual property S. 1848, Trade and Globalization Adjustment Assistance Act of 2007: trade adjustment assistance issues S. 2731, President's Emergency Plan For AIDS Relief (PEPFAR): intellectual property, access to medicines and public health S. 3083, Trade Reform, Accountability, Development, and Employment Act of 2008 (TRADE Act of 2008): intellectual property Colombia Free Trade Agreement: intellectual property, market access and public health Korea Free Trade Agreement: intellectual property, market access and public health Implementation of Peru Free Trade Agreement: intellectual property, market access and public health World Health Organization (WHO) Intergovernmental Working Group on Public Health, Innovation and Intellectual Property (IGWG): intellectual property, access and public health World Trade Organization (WTO) intellectual property enforcement issues International market access and intellectual property issues

H.R. 3920, Trade and Globalization Assistance Act of 2007: trade adjustment assistance issues H.R. 5501, President's Emergency Plan For AIDS Relief (PEPFAR): intellectual property, access to medicines and public health S. 1848, Trade and Globalization Adjustment Assistance Act of 2007: trade adjustment assistance issues S.2731, President's Emergency Plan For AIDS Relief (PEPFAR): intellectual property, access to medicines and public health Colombia Free Trade Agreement: intellectual property, market access and public health Korea Free Trade Agreement: intellectual property, market access and public health Implementation of Peru Free Trade Agreement: intellectual property, market access and public health World Health Organization (WHO) Intergovernmental Working Group on Public Health, Innovation and Intellectual Property (IGWG): intellectual property, access and public health International market access and intellectual property issues

H.R. 3920, Trade and Globalization Assistance Act of 2007: trade adjustment assistance issues H.R. 5501, President's Emergency Plan For AIDS Relief (PEPFAR): intellectual property, access to medicines and public health H.R. 6180, Trade Reform, Accountability, Development, and Employment Act of 2008 (TRADE Act of 2008): intellectual property S. 1848, Trade and Globalization Adjustment Assistance Act of 2007: trade adjustment assistance issues S.2731, President's Emergency Plan For AIDS Relief (PEPFAR): intellectual property, access to medicines and public health S.3083, Trade Reform, Accountability, Development, and Employment Act of 2008 (TRADE Act of 2008): intellectual property Colombia Free Trade Agreement: intellectual property, market access and public health Korea Free Trade Agreement: intellectual property, market access and public health Implementation of Peru Free Trade Agreement: intellectual property, market access and public health World Trade Organization intellectual property enforcement issues International market access and intellectual property issues

H.R. 380, Pharmaceutical Market Access and Drug Safety Act of 2007: importation H.R. 1038, Access to Life-Saving Medicine Act: follow-on biologics H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007: follow-on biologics H.R. 3610, Food and Drug Import Safety Act of 2007: import safety H.R. 5629, Pathway for Biosimilars Act: follow-on biologics H.R. 5839, Safeguarding America's Pharmaceuticals Act of 2008: anti-counterfeiting H.R. 6151, Responsibility in Drug and Device Advertising Act of 2008: Direct-to-consumer drug advertising H.R. 6381, Medical Device Safety Act of 2008: preemption issues H.R. 6820, Water Assessment and Treatment Evaluation Research Study Act of 2008: pharmaceuticals in drinking water and human health S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007: importation S. 334, Healthy Americans Act: non-interference S. 623, Access to Life-Saving Medicine Act: follow-on biologics S. 1693, Wired for Health Care Quality Act: health information technology and health care quality and costs S. 1695, Biologics Price Competition and Innovation Act of 2007: follow-on biologics S. 2663, CPSC Reform Act: importation S. 3046, Access, Compassion, Care, and Ethics for Seriously Ill Patients Act (ACCESS Act): access to investigational drugs and related issues S. 3398, Medical Device Safety Act of 2008: preemption issues S. 3409, Drug and Device Accountability Act of 2008: import safety S. 3560, QI Program Supplemental Funding Act of 2008: antibiotic exclusivity provisions S. 3633, Transparency in Drug Labeling Act: country of origin labeling for drugs

H.R. 380, Pharmaceutical Market Access and Drug Safety Act of 2007: importation H.R. 1038, Access to Life-Saving Medicine Act: follow-on biologics H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007: follow-on biologics H.R. 3610, Food and Drug Import Safety Act of 2007: import safety H.R. 5629, Pathway for Biosimilars Act: follow-on biologics H.R. 5839, Safeguarding America's Pharmaceuticals Act of 2008: anti-counterfeiting H.R. 6151, Responsibility in Drug and Device Advertising Act of 2008: Direct-to-consumer drug advertising H.R. 6381, Medical Device Safety Act of 2008: preemption issues H.R. 6820, Water Assessment and Treatment Evaluation Research Study Act of 2008: pharmaceuticals in drinking water and human health S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007: importation S. 334, Healthy Americans Act: non-interference S. 623, Access to Life-Saving Medicine Act: follow-on biologics S. 1693, Wired for Health Care Quality Act: health information technology and health care quality and costs S. 1695, Biologics Price Competition and Innovation Act of 2007: follow-on biologics S. 2663, CPSC Reform Act: importation S. 3046, Access, Compassion, Care, and Ethics for Seriously Ill Patients Act (ACCESS Act): access to investigational drugs and related issues S. 3398, Medical Device Safety Act of 2008: preemption issues S. 3409, Drug and Device Accountability Act of 2008: import safety S. 3560, QI Program Supplemental Funding Act of 2008: antibiotic exclusivity provisions S. 3633, Transparency in Drug Labeling Act: country of origin labeling for drugs

H.R. 380, Pharmaceutical Market Access and Drug Safety Act of 2007: importation H.R. 1038, Access to Life-Saving Medicine Act: follow-on biologics H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007: follow-on biologics H.R. 3610, Food and Drug Import Safety Act of 2007: import safety H.R. 5629, Pathway for Biosimilars Act: follow-on biologics H.R. 5839, Safeguarding America's Pharmaceuticals Act of 2008: anti-counterfeiting H.R. 6151, Responsibility in Drug and Device Advertising Act of 2008: Direct-to-consumer drug advertising H.R. 6381, Medical Device Safety Act of 2008: preemption issues H.R. 6820, Water Assessment and Treatment Evaluation Research Study Act of 2008: pharmaceuticals in drinking water and human health S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007: importation S. 334, Healthy Americans Act: non-interference S. 623, Access to Life-Saving Medicine Act: follow-on biologics S. 1693, Wired for Health Care Quality Act: health information technology and health care quality and costs S. 1695, Biologics Price Competition and Innovation Act of 2007: follow-on biologics S. 2663, CPSC Reform Act: importation S. 3046, Access, Compassion, Care, and Ethics for Seriously Ill Patients Act (ACCESS Act): access to investigational drugs and related issues S. 3398, Medical Device Safety Act of 2008: preemption issues S. 3409, Drug and Device Accountability Act of 2008: import safety S. 3560, QI Program Supplemental Funding Act of 2008: antibiotic exclusivity provisions S. 3633, Transparency in Drug Labeling Act: country of origin labeling for drugs

H.R. 3920, Trade and Globalization Assistance Act of 2007: trade adjustment assistance issues H.R. 5501, President's Emergency Plan For AIDS Relief (PEPFAR): intellectual property, access to medicines and public health H.R. 6180, Trade Reform, Accountability, Development, and Employment Act of 2008 (TRADE Act of 2008): intellectual property S. 1848, Trade and Globalization Adjustment Assistance Act of 2007: trade adjustment assistance issues S. 2731, President's Emergency Plan For AIDS Relief (PEPFAR): intellectual property, access to medicines and public health S. 3083, Trade Reform, Accountability, Development, and Employment Act of 2008 (TRADE Act of 2008): intellectual property Colombia Free Trade Agreement: intellectual property, market access and public health Korea Free Trade Agreement: intellectual property, market access and public health Implementation of Peru Free Trade Agreement: intellectual property, market access and public health World Health Organization (WHO) Intergovernmental Working Group on Public Health, Innovation and Intellectual Property (IGWG): intellectual property, access and public health World Trade Organization (WTO) intellectual property enforcement issues International market access and intellectual property issues

H.R. 3920, Trade and Globalization Assistance Act of 2007: trade adjustment assistance issues H.R. 5501, President's Emergency Plan For AIDS Relief (PEPFAR): intellectual property, access to medicines and public health H.R. 6180, Trade Reform, Accountability, Development, and Employment Act of 2008 (TRADE Act of 2008): intellectual property S. 1848, Trade and Globalization Adjustment Assistance Act of 2007: trade adjustment assistance issues S.2731, President's Emergency Plan For AIDS Relief (PEPFAR): intellectual property, access to medicines and public health S.3083, Trade Reform, Accountability, Development, and Employment Act of 2008 (TRADE Act of 2008): intellectual property Colombia Free Trade Agreement: intellectual property, market access and public health Korea Free Trade Agreement: intellectual property, market access and public health Implementation of Peru Free Trade Agreement: intellectual property, market access and public health World Trade Organization intellectual property enforcement issues International market access and intellectual property issues

H.R. 3920, Trade and Globalization Assistance Act of 2007: trade adjustment assistance issues H.R. 6180, Trade Reform, Accountability, Development, and Employment Act of 2008 (TRADE Act of 2008): intellectual property S. 1848, Trade and Globalization Adjustment Assistance Act of 2007: trade adjustment assistance issues S.3083, Trade Reform, Accountability, Development, and Employment Act of 2008 (TRADE Act of 2008): intellectual property Colombia Free Trade Agreement: intellectual property, market access and public health Korea Free Trade Agreement: intellectual property, market access and public health Implementation of Peru Free Trade Agreement: intellectual property, market access and public health International market access and intellectual property issues

H.R. 380, Pharmaceutical Market Access and Drug Safety Act of 2007: importation H.R. 1038, Access to Life-Saving Medicine Act: follow-on biologics H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007: follow-on biologics H.R. 3610, Food and Drug Import Safety Act of 2007: import safety H.R. 5629, Pathway for Biosimilars Act: follow-on biologics H.R. 5839, Safeguarding America's Pharmaceuticals Act of 2008: anti-counterfeiting H.R. 6151, Responsibility in Drug and Device Advertising Act of 2008: Direct-to-consumer drug advertising H.R. 6381, Medical Device Safety Act of 2008: preemption issues H.R. 6820, Water Assessment and Treatment Evaluation Research Study Act of 2008: pharmaceuticals in drinking water and human health S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007: importation S. 334, Healthy Americans Act: non-interference S. 623, Access to Life-Saving Medicine Act: follow-on biologics S. 1693, Wired for Health Care Quality Act: health information technology and health care quality and costs S. 1695, Biologics Price Competition and Innovation Act of 2007: follow-on biologics S. 2663, CPSC Reform Act: importation S. 3046, Access, Compassion, Care, and Ethics for Seriously Ill Patients Act (ACCESS Act): access to investigational drugs and related issues S. 3398, Medical Device Safety Act of 2008: preemption issues S. 3409, Drug and Device Accountability Act of 2008: import safety S. 3560, QI Program Supplemental Funding Act of 2008: antibiotic exclusivity provisions S. 3633, Transparency in Drug Labeling Act: country of origin labeling for drugs

H.R. 380, Pharmaceutical Market Access and Drug Safety Act of 2007: importation H.R. 1038, Access to Life-Saving Medicine Act: follow-on biologics H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007: follow-on biologics H.R. 3610, Food and Drug Import Safety Act of 2007: import safety H.R. 5629, Pathway for Biosimilars Act: follow-on biologics H.R. 5839, Safeguarding America's Pharmaceuticals Act of 2008: anti-counterfeiting H.R. 6151, Responsibility in Drug and Device Advertising Act of 2008: Direct-to-consumer drug advertising H.R. 6381, Medical Device Safety Act of 2008: preemption issues H.R. 6820, Water Assessment and Treatment Evaluation Research Study Act of 2008: pharmaceuticals in drinking water and human health S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007: importation S. 334, Healthy Americans Act: non-interference S. 623, Access to Life-Saving Medicine Act: follow-on biologics S. 1693, Wired for Health Care Quality Act: health information technology and health care quality and costs S. 1695, Biologics Price Competition and Innovation Act of 2007: follow-on biologics S. 2663, CPSC Reform Act: importation S. 3046, Access, Compassion, Care, and Ethics for Seriously Ill Patients Act (ACCESS Act): access to investigational drugs and related issues S. 3398, Medical Device Safety Act of 2008: preemption issues S. 3409, Drug and Device Accountability Act of 2008: import safety S. 3560, QI Program Supplemental Funding Act of 2008: antibiotic exclusivity provisions S. 3633, Transparency in Drug Labeling Act: country of origin labeling for drugs

H.R. 1902, Protecting Consumer Access to Generic Drugs Act of 2007: patent settlements H.R. 1908, Patent Reform Act of 2007: patent issues S. 1145, Patent Reform Act of 2007: patent issues S. 316, Preserve Access to Affordable Generics Act: patent settlements Preparation for Senate reauthorization of the Federal Trade Commission (no bill introduced yet) International intellectual property issues

H.R. 1902, Protecting Consumer Access to Generic Drugs Act of 2007: patent settlements H.R. 1908, Patent Reform Act of 2007: patent issues H.R. 4279, Prioritizing Resources and Organization for Intellectual Property Act of 2007: enforcement S. 316, Preserve Access to Affordable Generics Act: patent settlements S. 522, Intellectual Property Rights Enforcement Act: anti-counterfeiting and enforcement S. 1145, Patent Reform Act of 2007: patent issues S.2317, Intellectual Property Enforcement Act of 2007: enforcement S.3325, Prioritizing Resources and Organization for Intellectual Property Act of 2008: enforcement S.3600, Patent Reform Act of 2008: patent reform and related issues International intellectual property issues

H.R. 1902, Protecting Consumer Access to Generic Drugs Act of 2007: patent settlements H.R. 1908, Patent Reform Act of 2007: patent issues H.R. 4279, Prioritizing Resources and Organization for Intellectual Property Act of 2007: enforcement S. 316, Preserve Access to Affordable Generics Act: patent settlements S. 522, Intellectual Property Rights Enforcement Act: anti-counterfeiting and enforcement S. 1145, Patent Reform Act of 2007: patent issues S. 2317, Intellectual Property Enforcement Act of 2007: enforcement Senate reauthorization of the Federal Trade Commission (no bill introduced during reporting period) International intellectual property issues

H.R. 1902, Protecting Consumer Access to Generic Drugs Act of 2007: patent settlements H.R. 1908, Patent Reform Act of 2007: patent system reform and related issues such as obtaining/opposing patents and remedies H.R. 4279, Prioritizing Resources and Organization for Intellectual Property Act of 2007: enforcement S. 316, Preserve Access to Affordable Generics Act: patent settlements S. 522, Intellectual Property Rights Enforcement Act: anti-counterfeiting and enforcement S. 1145, Patent Reform Act of 2007: patent system reform and related issues such as obtaining/opposing patents and remedies S. 2317, Intellectual Property Enforcement Act of 2007: enforcement S. 3325, Prioritizing Resources and Organization for Intellectual Property Act of 2008: enforcement S. 3464, International Intellectual Property Protection and Enforcement Act of 2008: enforcement S. 3600, Patent Reform Act of 2008: patent system reform and related issues such as obtaining/opposing patents and remedies International intellectual property issues

H.R. 380, Pharmaceutical Market Access and Drug Safety Act of 2007: importation H.R. 1038, Access to Life-Saving Medicine Act: follow-on biologics H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007: follow-on biologics H.R. 3610, Food and Drug Import Safety Act of 2007: import safety H.R. 5629, Pathway for Biosimilars Act: follow-on biologics H.R. 5839, Safeguarding America's Pharmaceuticals Act of 2008: anti-counterfeiting H.R. 6151, Responsibility in Drug and Device Advertising Act of 2008: Direct-to-consumer drug advertising H.R. 6381, Medical Device Safety Act of 2008: preemption issues H.R. 6820, Water Assessment and Treatment Evaluation Research Study Act of 2008: pharmaceuticals in drinking water and human health S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007: importation S. 334, Healthy Americans Act: non-interference S. 623, Access to Life-Saving Medicine Act: follow-on biologics S. 1693, Wired for Health Care Quality Act: health information technology and health care quality and costs S. 1695, Biologics Price Competition and Innovation Act of 2007: follow-on biologics S. 2663, CPSC Reform Act: importation S. 3046, Access, Compassion, Care, and Ethics for Seriously Ill Patients Act (ACCESS Act): access to investigational drugs and related issues S. 3398, Medical Device Safety Act of 2008: preemption issues S. 3409, Drug and Device Accountability Act of 2008: import safety S. 3560, QI Program Supplemental Funding Act of 2008: antibiotic exclusivity provisions S. 3633, Transparency in Drug Labeling Act: country of origin labeling for drugs

H.R. 380, Pharmaceutical Market Access and Drug Safety Act of 2007: importation H.R. 1038, Access to Life-Saving Medicine Act: follow-on biologics H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007: follow-on biologics H.R. 3610, Food and Drug Import Safety Act of 2007: import safety H.R. 5629, Pathway for Biosimilars Act: follow-on biologics H.R. 5839, Safeguarding America's Pharmaceuticals Act of 2008: anti-counterfeiting H.R. 6151, Responsibility in Drug and Device Advertising Act of 2008: Direct-to-consumer drug advertising H.R. 6381, Medical Device Safety Act of 2008: preemption issues H.R. 6820, Water Assessment and Treatment Evaluation Research Study Act of 2008: pharmaceuticals in drinking water and human health S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007: importation S. 334, Healthy Americans Act: non-interference S. 623, Access to Life-Saving Medicine Act: follow-on biologics S. 1693, Wired for Health Care Quality Act: health information technology and health care quality and costs S. 1695, Biologics Price Competition and Innovation Act of 2007: follow-on biologics S. 2663, CPSC Reform Act: importation S. 3046, Access, Compassion, Care, and Ethics for Seriously Ill Patients Act (ACCESS Act): access to investigational drugs and related issues S. 3398, Medical Device Safety Act of 2008: preemption issues S. 3409, Drug and Device Accountability Act of 2008: import safety S. 3560, QI Program Supplemental Funding Act of 2008: antibiotic exclusivity provisions S. 3633, Transparency in Drug Labeling Act: country of origin labeling for drugs

H.R. 3920, Trade and Globalization Assistance Act of 2007: trade adjustment assistance issues H.R. 5501, President's Emergency Plan For AIDS Relief (PEPFAR): intellectual property, access to medicines and public health S. 1848, Trade and Globalization Adjustment Assistance Act of 2007: trade adjustment assistance issues S.2731, President's Emergency Plan For AIDS Relief (PEPFAR): intellectual property, access to medicines and public health Colombia Free Trade Agreement: intellectual property, market access and public health Korea Free Trade Agreement: intellectual property, market access and public health Implementation of Peru Free Trade Agreement: intellectual property, market access and public health World Health Organization (WHO) Intergovernmental Working Group on Public Health, Innovation and Intellectual Property (IGWG): intellectual property, access and public health International market access and intellectual property issues

H.R. 3920, Trade and Globalization Assistance Act of 2007: trade adjustment assistance issues H.R. 5501, President's Emergency Plan For AIDS Relief (PEPFAR): intellectual property, access to medicines and public health H.R. 6180, Trade Reform, Accountability, Development, and Employment Act of 2008 (TRADE Act of 2008): intellectual property S. 1848, Trade and Globalization Adjustment Assistance Act of 2007: trade adjustment assistance issues S. 2731, President's Emergency Plan For AIDS Relief (PEPFAR): intellectual property, access to medicines and public health S. 3083, Trade Reform, Accountability, Development, and Employment Act of 2008 (TRADE Act of 2008): intellectual property Colombia Free Trade Agreement: intellectual property, market access and public health Korea Free Trade Agreement: intellectual property, market access and public health Implementation of Peru Free Trade Agreement: intellectual property, market access and public health World Health Organization (WHO) Intergovernmental Working Group on Public Health, Innovation and Intellectual Property (IGWG): intellectual property, access and public health World Trade Organization (WTO) intellectual property enforcement issues International market access and intellectual property issues

H.R. 3920, Trade and Globalization Assistance Act of 2007: trade adjustment assistance issues H.R. 6180, Trade Reform, Accountability, Development, and Employment Act of 2008 (TRADE Act of 2008): intellectual property S. 1848, Trade and Globalization Adjustment Assistance Act of 2007: trade adjustment assistance issues S.3083, Trade Reform, Accountability, Development, and Employment Act of 2008 (TRADE Act of 2008): intellectual property Colombia Free Trade Agreement: intellectual property, market access and public health Korea Free Trade Agreement: intellectual property, market access and public health Implementation of Peru Free Trade Agreement: intellectual property, market access and public health International market access and intellectual property issues

H.R. 3920, Trade and Globalization Assistance Act of 2007: trade adjustment assistance issues H.R. 5501, President's Emergency Plan For AIDS Relief (PEPFAR): intellectual property, access to medicines and public health H.R. 6180, Trade Reform, Accountability, Development, and Employment Act of 2008 (TRADE Act of 2008): intellectual property S. 1848, Trade and Globalization Adjustment Assistance Act of 2007: trade adjustment assistance issues S.2731, President's Emergency Plan For AIDS Relief (PEPFAR): intellectual property, access to medicines and public health S.3083, Trade Reform, Accountability, Development, and Employment Act of 2008 (TRADE Act of 2008): intellectual property Colombia Free Trade Agreement: intellectual property, market access and public health Korea Free Trade Agreement: intellectual property, market access and public health Implementation of Peru Free Trade Agreement: intellectual property, market access and public health World Trade Organization intellectual property enforcement issues International market access and intellectual property issues

H.R. 1902, Protecting Consumer Access to Generic Drugs Act of 2007: patent settlements H.R. 1908, Patent Reform Act of 2007: patent system reform and related issues such as obtaining/opposing patents and remedies H.R. 4279, Prioritizing Resources and Organization for Intellectual Property Act of 2007: enforcement S. 316, Preserve Access to Affordable Generics Act: patent settlements S. 522, Intellectual Property Rights Enforcement Act: anti-counterfeiting and enforcement S. 1145, Patent Reform Act of 2007: patent system reform and related issues such as obtaining/opposing patents and remedies S. 2317, Intellectual Property Enforcement Act of 2007: enforcement S. 3325, Prioritizing Resources and Organization for Intellectual Property Act of 2008: enforcement S. 3464, International Intellectual Property Protection and Enforcement Act of 2008: enforcement S. 3600, Patent Reform Act of 2008: patent system reform and related issues such as obtaining/opposing patents and remedies International intellectual property issues

H.R. 1902, Protecting Consumer Access to Generic Drugs Act of 2007: patent settlements H.R. 1908, Patent Reform Act of 2007: patent issues H.R. 4279, Prioritizing Resources and Organization for Intellectual Property Act of 2007: enforcement S. 316, Preserve Access to Affordable Generics Act: patent settlements S. 522, Intellectual Property Rights Enforcement Act: anti-counterfeiting and enforcement S. 1145, Patent Reform Act of 2007: patent issues S.2317, Intellectual Property Enforcement Act of 2007: enforcement S.3325, Prioritizing Resources and Organization for Intellectual Property Act of 2008: enforcement S.3600, Patent Reform Act of 2008: patent reform and related issues International intellectual property issues

H.R. 1902, Protecting Consumer Access to Generic Drugs Act of 2007: patent settlements H.R. 1908, Patent Reform Act of 2007: patent issues H.R. 4279, Prioritizing Resources and Organization for Intellectual Property Act of 2007: enforcement S. 316, Preserve Access to Affordable Generics Act: patent settlements S. 522, Intellectual Property Rights Enforcement Act: anti-counterfeiting and enforcement S. 1145, Patent Reform Act of 2007: patent issues S. 2317, Intellectual Property Enforcement Act of 2007: enforcement Senate reauthorization of the Federal Trade Commission (no bill introduced during reporting period) International intellectual property issues

H.R. 380, Pharmaceutical Market Access and Drug Safety Act of 2007: importation H.R. 1038, Access to Life-Saving Medicine Act: follow-on biologics H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007: follow-on biologics H.R. 3610, Food and Drug Import Safety Act of 2007: import safety H.R. 5629, Pathway for Biosimilars Act: follow-on biologics H.R. 5839, Safeguarding America's Pharmaceuticals Act of 2008: anti-counterfeiting H.R. 6151, Responsibility in Drug and Device Advertising Act of 2008: Direct-to-consumer drug advertising H.R. 6381, Medical Device Safety Act of 2008: preemption issues H.R. 6820, Water Assessment and Treatment Evaluation Research Study Act of 2008: pharmaceuticals in drinking water and human health S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007: importation S. 334, Healthy Americans Act: non-interference S. 623, Access to Life-Saving Medicine Act: follow-on biologics S. 1693, Wired for Health Care Quality Act: health information technology and health care quality and costs S. 1695, Biologics Price Competition and Innovation Act of 2007: follow-on biologics S. 2663, CPSC Reform Act: importation S. 3046, Access, Compassion, Care, and Ethics for Seriously Ill Patients Act (ACCESS Act): access to investigational drugs and related issues S. 3398, Medical Device Safety Act of 2008: preemption issues S. 3409, Drug and Device Accountability Act of 2008: import safety S. 3560, QI Program Supplemental Funding Act of 2008: antibiotic exclusivity provisions S. 3633, Transparency in Drug Labeling Act: country of origin labeling for drugs

H.R. 3920, Trade and Globalization Assistance Act of 2007: trade adjustment assistance issues H.R. 5501, President's Emergency Plan For AIDS Relief (PEPFAR): intellectual property, access to medicines and public health H.R. 6180, Trade Reform, Accountability, Development, and Employment Act of 2008 (TRADE Act of 2008): intellectual property S. 1848, Trade and Globalization Adjustment Assistance Act of 2007: trade adjustment assistance issues S. 2731, President's Emergency Plan For AIDS Relief (PEPFAR): intellectual property, access to medicines and public health S. 3083, Trade Reform, Accountability, Development, and Employment Act of 2008 (TRADE Act of 2008): intellectual property Colombia Free Trade Agreement: intellectual property, market access and public health Korea Free Trade Agreement: intellectual property, market access and public health Implementation of Peru Free Trade Agreement: intellectual property, market access and public health World Health Organization (WHO) Intergovernmental Working Group on Public Health, Innovation and Intellectual Property (IGWG): intellectual property, access and public health World Trade Organization (WTO) intellectual property enforcement issues International market access and intellectual property issues

H.R. 3920, Trade and Globalization Assistance Act of 2007: trade adjustment assistance issues H.R. 5501, President's Emergency Plan For AIDS Relief (PEPFAR): intellectual property, access to medicines and public health H.R. 6180, Trade Reform, Accountability, Development, and Employment Act of 2008 (TRADE Act of 2008): intellectual property S. 1848, Trade and Globalization Adjustment Assistance Act of 2007: trade adjustment assistance issues S.2731, President's Emergency Plan For AIDS Relief (PEPFAR): intellectual property, access to medicines and public health S.3083, Trade Reform, Accountability, Development, and Employment Act of 2008 (TRADE Act of 2008): intellectual property Colombia Free Trade Agreement: intellectual property, market access and public health Korea Free Trade Agreement: intellectual property, market access and public health Implementation of Peru Free Trade Agreement: intellectual property, market access and public health World Trade Organization intellectual property enforcement issues International market access and intellectual property issues

H.R. 3920, Trade and Globalization Assistance Act of 2007: trade adjustment assistance issues H.R. 5501, President's Emergency Plan For AIDS Relief (PEPFAR): intellectual property, access to medicines and public health S. 1848, Trade and Globalization Adjustment Assistance Act of 2007: trade adjustment assistance issues S.2731, President's Emergency Plan For AIDS Relief (PEPFAR): intellectual property, access to medicines and public health Colombia Free Trade Agreement: intellectual property, market access and public health Korea Free Trade Agreement: intellectual property, market access and public health Implementation of Peru Free Trade Agreement: intellectual property, market access and public health World Health Organization (WHO) Intergovernmental Working Group on Public Health, Innovation and Intellectual Property (IGWG): intellectual property, access and public health International market access and intellectual property issues

H.R. 380, Pharmaceutical Market Access and Drug Safety Act of 2007: importation H.R. 1038, Access to Life-Saving Medicine Act: follow-on biologics H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007: follow-on biologics H.R. 3610, Food and Drug Import Safety Act of 2007: import safety H.R. 5629, Pathway for Biosimilars Act: follow-on biologics H.R. 5839, Safeguarding America's Pharmaceuticals Act of 2008: anti-counterfeiting H.R. 6151, Responsibility in Drug and Device Advertising Act of 2008: Direct-to-consumer drug advertising H.R. 6381, Medical Device Safety Act of 2008: preemption issues H.R. 6820, Water Assessment and Treatment Evaluation Research Study Act of 2008: pharmaceuticals in drinking water and human health S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007: importation S. 334, Healthy Americans Act: non-interference S. 623, Access to Life-Saving Medicine Act: follow-on biologics S. 1693, Wired for Health Care Quality Act: health information technology and health care quality and costs S. 1695, Biologics Price Competition and Innovation Act of 2007: follow-on biologics S. 2663, CPSC Reform Act: importation S. 3046, Access, Compassion, Care, and Ethics for Seriously Ill Patients Act (ACCESS Act): access to investigational drugs and related issues S. 3398, Medical Device Safety Act of 2008: preemption issues S. 3409, Drug and Device Accountability Act of 2008: import safety S. 3560, QI Program Supplemental Funding Act of 2008: antibiotic exclusivity provisions S. 3633, Transparency in Drug Labeling Act: country of origin labeling for drugs

H.R. 3920, Trade and Globalization Assistance Act of 2007: trade adjustment assistance issues H.R. 5501, President's Emergency Plan For AIDS Relief (PEPFAR): intellectual property, access to medicines and public health H.R. 6180, Trade Reform, Accountability, Development, and Employment Act of 2008 (TRADE Act of 2008): intellectual property S. 1848, Trade and Globalization Adjustment Assistance Act of 2007: trade adjustment assistance issues S.2731, President's Emergency Plan For AIDS Relief (PEPFAR): intellectual property, access to medicines and public health S.3083, Trade Reform, Accountability, Development, and Employment Act of 2008 (TRADE Act of 2008): intellectual property Colombia Free Trade Agreement: intellectual property, market access and public health Korea Free Trade Agreement: intellectual property, market access and public health Implementation of Peru Free Trade Agreement: intellectual property, market access and public health World Trade Organization intellectual property enforcement issues International market access and intellectual property issues

H.R. 3920, Trade and Globalization Assistance Act of 2007: trade adjustment assistance issues H.R. 5501, President's Emergency Plan For AIDS Relief (PEPFAR): intellectual property, access to medicines and public health H.R. 6180, Trade Reform, Accountability, Development, and Employment Act of 2008 (TRADE Act of 2008): intellectual property S. 1848, Trade and Globalization Adjustment Assistance Act of 2007: trade adjustment assistance issues S. 2731, President's Emergency Plan For AIDS Relief (PEPFAR): intellectual property, access to medicines and public health S. 3083, Trade Reform, Accountability, Development, and Employment Act of 2008 (TRADE Act of 2008): intellectual property Colombia Free Trade Agreement: intellectual property, market access and public health Korea Free Trade Agreement: intellectual property, market access and public health Implementation of Peru Free Trade Agreement: intellectual property, market access and public health World Health Organization (WHO) Intergovernmental Working Group on Public Health, Innovation and Intellectual Property (IGWG): intellectual property, access and public health World Trade Organization (WTO) intellectual property enforcement issues International market access and intellectual property issues

H.R. 3920, Trade and Globalization Assistance Act of 2007: trade adjustment assistance issues H.R. 6180, Trade Reform, Accountability, Development, and Employment Act of 2008 (TRADE Act of 2008): intellectual property S. 1848, Trade and Globalization Adjustment Assistance Act of 2007: trade adjustment assistance issues S.3083, Trade Reform, Accountability, Development, and Employment Act of 2008 (TRADE Act of 2008): intellectual property Colombia Free Trade Agreement: intellectual property, market access and public health Korea Free Trade Agreement: intellectual property, market access and public health Implementation of Peru Free Trade Agreement: intellectual property, market access and public health International market access and intellectual property issues

H.R. 1902, Protecting Consumer Access to Generic Drugs Act of 2007: patent settlements H.R. 1908, Patent Reform Act of 2007: patent system reform and related issues such as obtaining/opposing patents and remedies H.R. 4279, Prioritizing Resources and Organization for Intellectual Property Act of 2007: enforcement S. 316, Preserve Access to Affordable Generics Act: patent settlements S. 522, Intellectual Property Rights Enforcement Act: anti-counterfeiting and enforcement S. 1145, Patent Reform Act of 2007: patent system reform and related issues such as obtaining/opposing patents and remedies S. 2317, Intellectual Property Enforcement Act of 2007: enforcement S. 3325, Prioritizing Resources and Organization for Intellectual Property Act of 2008: enforcement S. 3464, International Intellectual Property Protection and Enforcement Act of 2008: enforcement S. 3600, Patent Reform Act of 2008: patent system reform and related issues such as obtaining/opposing patents and remedies International intellectual property issues

H.R. 1902, Protecting Consumer Access to Generic Drugs Act of 2007: patent settlements H.R. 1908, Patent Reform Act of 2007: patent issues H.R. 4279, Prioritizing Resources and Organization for Intellectual Property Act of 2007: enforcement S. 316, Preserve Access to Affordable Generics Act: patent settlements S. 522, Intellectual Property Rights Enforcement Act: anti-counterfeiting and enforcement S. 1145, Patent Reform Act of 2007: patent issues S. 2317, Intellectual Property Enforcement Act of 2007: enforcement Senate reauthorization of the Federal Trade Commission (no bill introduced during reporting period) International intellectual property issues

H.R. 1902, Protecting Consumer Access to Generic Drugs Act of 2007: patent settlements H.R. 1908, Patent Reform Act of 2007: patent issues H.R. 4279, Prioritizing Resources and Organization for Intellectual Property Act of 2007: enforcement S. 316, Preserve Access to Affordable Generics Act: patent settlements S. 522, Intellectual Property Rights Enforcement Act: anti-counterfeiting and enforcement S. 1145, Patent Reform Act of 2007: patent issues S.2317, Intellectual Property Enforcement Act of 2007: enforcement S.3325, Prioritizing Resources and Organization for Intellectual Property Act of 2008: enforcement S.3600, Patent Reform Act of 2008: patent reform and related issues International intellectual property issues

H.R. 1902, Protecting Consumer Access to Generic Drugs Act of 2007: patent settlements H.R. 1908, Patent Reform Act of 2007: patent issues S. 1145, Patent Reform Act of 2007: patent issues S. 316, Preserve Access to Affordable Generics Act: patent settlements Preparation for Senate reauthorization of the Federal Trade Commission (no bill introduced yet) International intellectual property issues

H.R. 1902, Protecting Consumer Access to Generic Drugs Act of 2007: patent settlements H.R. 1908, Patent Reform Act of 2007: patent system reform and related issues such as obtaining/opposing patents and remedies H.R. 4279, Prioritizing Resources and Organization for Intellectual Property Act of 2007: enforcement S. 316, Preserve Access to Affordable Generics Act: patent settlements S. 522, Intellectual Property Rights Enforcement Act: anti-counterfeiting and enforcement S. 1145, Patent Reform Act of 2007: patent system reform and related issues such as obtaining/opposing patents and remedies S. 2317, Intellectual Property Enforcement Act of 2007: enforcement S. 3325, Prioritizing Resources and Organization for Intellectual Property Act of 2008: enforcement S. 3464, International Intellectual Property Protection and Enforcement Act of 2008: enforcement S. 3600, Patent Reform Act of 2008: patent system reform and related issues such as obtaining/opposing patents and remedies International intellectual property issues

H.R. 1902, Protecting Consumer Access to Generic Drugs Act of 2007: patent settlements H.R. 1908, Patent Reform Act of 2007: patent issues H.R. 4279, Prioritizing Resources and Organization for Intellectual Property Act of 2007: enforcement S. 316, Preserve Access to Affordable Generics Act: patent settlements S. 522, Intellectual Property Rights Enforcement Act: anti-counterfeiting and enforcement S. 1145, Patent Reform Act of 2007: patent issues S.2317, Intellectual Property Enforcement Act of 2007: enforcement S.3325, Prioritizing Resources and Organization for Intellectual Property Act of 2008: enforcement S.3600, Patent Reform Act of 2008: patent reform and related issues International intellectual property issues

H.R. 380, Pharmaceutical Market Access and Drug Safety Act of 2007: importation H.R. 1038, Access to Life-Saving Medicine Act: follow-on biologics H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007: follow-on biologics H.R. 3610, Food and Drug Import Safety Act of 2007: import safety H.R. 5629, Pathway for Biosimilars Act: follow-on biologics H.R. 5839, Safeguarding America's Pharmaceuticals Act of 2008: anti-counterfeiting H.R. 6151, Responsibility in Drug and Device Advertising Act of 2008: Direct-to-consumer drug advertising H.R. 6381, Medical Device Safety Act of 2008: preemption issues H.R. 6820, Water Assessment and Treatment Evaluation Research Study Act of 2008: pharmaceuticals in drinking water and human health S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007: importation S. 334, Healthy Americans Act: non-interference S. 623, Access to Life-Saving Medicine Act: follow-on biologics S. 1693, Wired for Health Care Quality Act: health information technology and health care quality and costs S. 1695, Biologics Price Competition and Innovation Act of 2007: follow-on biologics S. 2663, CPSC Reform Act: importation S. 3046, Access, Compassion, Care, and Ethics for Seriously Ill Patients Act (ACCESS Act): access to investigational drugs and related issues S. 3398, Medical Device Safety Act of 2008: preemption issues S. 3409, Drug and Device Accountability Act of 2008: import safety S. 3560, QI Program Supplemental Funding Act of 2008: antibiotic exclusivity provisions S. 3633, Transparency in Drug Labeling Act: country of origin labeling for drugs

H.R. 380, Pharmaceutical Market Access and Drug Safety Act of 2007: importation H.R. 1038, Access to Life-Saving Medicine Act: follow-on biologics H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007: follow-on biologics H.R. 3610, Food and Drug Import Safety Act of 2007: import safety H.R. 5629, Pathway for Biosimilars Act: follow-on biologics H.R. 5839, Safeguarding America's Pharmaceuticals Act of 2008: anti-counterfeiting H.R. 6151, Responsibility in Drug and Device Advertising Act of 2008: Direct-to-consumer drug advertising H.R. 6381, Medical Device Safety Act of 2008: preemption issues H.R. 6820, Water Assessment and Treatment Evaluation Research Study Act of 2008: pharmaceuticals in drinking water and human health S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007: importation S. 334, Healthy Americans Act: non-interference S. 623, Access to Life-Saving Medicine Act: follow-on biologics S. 1693, Wired for Health Care Quality Act: health information technology and health care quality and costs S. 1695, Biologics Price Competition and Innovation Act of 2007: follow-on biologics S. 2663, CPSC Reform Act: importation S. 3046, Access, Compassion, Care, and Ethics for Seriously Ill Patients Act (ACCESS Act): access to investigational drugs and related issues S. 3398, Medical Device Safety Act of 2008: preemption issues S. 3409, Drug and Device Accountability Act of 2008: import safety S. 3560, QI Program Supplemental Funding Act of 2008: antibiotic exclusivity provisions S. 3633, Transparency in Drug Labeling Act: country of origin labeling for drugs

H.R. 380, Pharmaceutical Market Access and Drug Safety Act of 2007: importation H.R. 1038, Access to Life-Saving Medicine Act: follow-on biologics H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007: follow-on biologics H.R. 3610, Food and Drug Import Safety Act of 2007: import safety H.R. 5629, Pathway for Biosimilars Act: follow-on biologics H.R. 5839, Safeguarding America's Pharmaceuticals Act of 2008: anti-counterfeiting H.R. 6151, Responsibility in Drug and Device Advertising Act of 2008: Direct-to-consumer drug advertising H.R. 6381, Medical Device Safety Act of 2008: preemption issues H.R. 6820, Water Assessment and Treatment Evaluation Research Study Act of 2008: pharmaceuticals in drinking water and human health S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007: importation S. 334, Healthy Americans Act: non-interference S. 623, Access to Life-Saving Medicine Act: follow-on biologics S. 1693, Wired for Health Care Quality Act: health information technology and health care quality and costs S. 1695, Biologics Price Competition and Innovation Act of 2007: follow-on biologics S. 2663, CPSC Reform Act: importation S. 3046, Access, Compassion, Care, and Ethics for Seriously Ill Patients Act (ACCESS Act): access to investigational drugs and related issues S. 3398, Medical Device Safety Act of 2008: preemption issues S. 3409, Drug and Device Accountability Act of 2008: import safety S. 3560, QI Program Supplemental Funding Act of 2008: antibiotic exclusivity provisions S. 3633, Transparency in Drug Labeling Act: country of origin labeling for drugs

H.R. 1902, Protecting Consumer Access to Generic Drugs Act of 2007: patent settlements H.R. 1908, Patent Reform Act of 2007: patent system reform and related issues such as obtaining/opposing patents and remedies H.R. 4279, Prioritizing Resources and Organization for Intellectual Property Act of 2007: enforcement S. 316, Preserve Access to Affordable Generics Act: patent settlements S. 522, Intellectual Property Rights Enforcement Act: anti-counterfeiting and enforcement S. 1145, Patent Reform Act of 2007: patent system reform and related issues such as obtaining/opposing patents and remedies S. 2317, Intellectual Property Enforcement Act of 2007: enforcement S. 3325, Prioritizing Resources and Organization for Intellectual Property Act of 2008: enforcement S. 3464, International Intellectual Property Protection and Enforcement Act of 2008: enforcement S. 3600, Patent Reform Act of 2008: patent system reform and related issues such as obtaining/opposing patents and remedies International intellectual property issues

H.R. 380, Pharmaceutical Market Access and Drug Safety Act of 2007: importation H.R. 1038, Access to Life-Saving Medicine Act: follow-on biologics H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007: follow-on biologics H.R. 3610, Food and Drug Import Safety Act of 2007: import safety H.R. 5629, Pathway for Biosimilars Act: follow-on biologics H.R. 5839, Safeguarding America's Pharmaceuticals Act of 2008: anti-counterfeiting H.R. 6151, Responsibility in Drug and Device Advertising Act of 2008: Direct-to-consumer drug advertising H.R. 6381, Medical Device Safety Act of 2008: preemption issues H.R. 6820, Water Assessment and Treatment Evaluation Research Study Act of 2008: pharmaceuticals in drinking water and human health S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007: importation S. 334, Healthy Americans Act: non-interference S. 623, Access to Life-Saving Medicine Act: follow-on biologics S. 1693, Wired for Health Care Quality Act: health information technology and health care quality and costs S. 1695, Biologics Price Competition and Innovation Act of 2007: follow-on biologics S. 2663, CPSC Reform Act: importation S. 3046, Access, Compassion, Care, and Ethics for Seriously Ill Patients Act (ACCESS Act): access to investigational drugs and related issues S. 3398, Medical Device Safety Act of 2008: preemption issues S. 3409, Drug and Device Accountability Act of 2008: import safety S. 3560, QI Program Supplemental Funding Act of 2008: antibiotic exclusivity provisions S. 3633, Transparency in Drug Labeling Act: country of origin labeling for drugs

H.R. 1902, Protecting Consumer Access to Generic Drugs Act of 2007: patent settlements H.R. 1908, Patent Reform Act of 2007: patent system reform and related issues such as obtaining/opposing patents and remedies H.R. 4279, Prioritizing Resources and Organization for Intellectual Property Act of 2007: enforcement S. 316, Preserve Access to Affordable Generics Act: patent settlements S. 522, Intellectual Property Rights Enforcement Act: anti-counterfeiting and enforcement S. 1145, Patent Reform Act of 2007: patent system reform and related issues such as obtaining/opposing patents and remedies S. 2317, Intellectual Property Enforcement Act of 2007: enforcement S. 3325, Prioritizing Resources and Organization for Intellectual Property Act of 2008: enforcement S. 3464, International Intellectual Property Protection and Enforcement Act of 2008: enforcement S. 3600, Patent Reform Act of 2008: patent system reform and related issues such as obtaining/opposing patents and remedies International intellectual property issues

H.R. 1902, Protecting Consumer Access to Generic Drugs Act of 2007: patent settlements H.R. 1908, Patent Reform Act of 2007: patent issues H.R. 4279, Prioritizing Resources and Organization for Intellectual Property Act of 2007: enforcement S. 316, Preserve Access to Affordable Generics Act: patent settlements S. 522, Intellectual Property Rights Enforcement Act: anti-counterfeiting and enforcement S. 1145, Patent Reform Act of 2007: patent issues S.2317, Intellectual Property Enforcement Act of 2007: enforcement S.3325, Prioritizing Resources and Organization for Intellectual Property Act of 2008: enforcement S.3600, Patent Reform Act of 2008: patent reform and related issues International intellectual property issues

H.R. 380, Pharmaceutical Market Access and Drug Safety Act of 2007: importation H.R. 1038, Access to Life-Saving Medicine Act: follow-on biologics H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007: follow-on biologics H.R. 3610, Food and Drug Import Safety Act of 2007: import safety H.R. 5629, Pathway for Biosimilars Act: follow-on biologics H.R. 5839, Safeguarding America's Pharmaceuticals Act of 2008: anti-counterfeiting H.R. 6151, Responsibility in Drug and Device Advertising Act of 2008: Direct-to-consumer drug advertising H.R. 6381, Medical Device Safety Act of 2008: preemption issues H.R. 6820, Water Assessment and Treatment Evaluation Research Study Act of 2008: pharmaceuticals in drinking water and human health S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007: importation S. 334, Healthy Americans Act: non-interference S. 623, Access to Life-Saving Medicine Act: follow-on biologics S. 1693, Wired for Health Care Quality Act: health information technology and health care quality and costs S. 1695, Biologics Price Competition and Innovation Act of 2007: follow-on biologics S. 2663, CPSC Reform Act: importation S. 3046, Access, Compassion, Care, and Ethics for Seriously Ill Patients Act (ACCESS Act): access to investigational drugs and related issues S. 3398, Medical Device Safety Act of 2008: preemption issues S. 3409, Drug and Device Accountability Act of 2008: import safety S. 3560, QI Program Supplemental Funding Act of 2008: antibiotic exclusivity provisions S. 3633, Transparency in Drug Labeling Act: country of origin labeling for drugs

H.R. 1902, Protecting Consumer Access to Generic Drugs Act of 2007: patent settlements H.R. 1908, Patent Reform Act of 2007: patent issues H.R. 4279, Prioritizing Resources and Organization for Intellectual Property Act of 2007: enforcement S. 316, Preserve Access to Affordable Generics Act: patent settlements S. 522, Intellectual Property Rights Enforcement Act: anti-counterfeiting and enforcement S. 1145, Patent Reform Act of 2007: patent issues S. 2317, Intellectual Property Enforcement Act of 2007: enforcement Senate reauthorization of the Federal Trade Commission (no bill introduced during reporting period) International intellectual property issues

H.R. 1902, Protecting Consumer Access to Generic Drugs Act of 2007: patent settlements H.R. 1908, Patent Reform Act of 2007: patent system reform and related issues such as obtaining/opposing patents and remedies H.R. 4279, Prioritizing Resources and Organization for Intellectual Property Act of 2007: enforcement S. 316, Preserve Access to Affordable Generics Act: patent settlements S. 522, Intellectual Property Rights Enforcement Act: anti-counterfeiting and enforcement S. 1145, Patent Reform Act of 2007: patent system reform and related issues such as obtaining/opposing patents and remedies S. 2317, Intellectual Property Enforcement Act of 2007: enforcement S. 3325, Prioritizing Resources and Organization for Intellectual Property Act of 2008: enforcement S. 3464, International Intellectual Property Protection and Enforcement Act of 2008: enforcement S. 3600, Patent Reform Act of 2008: patent system reform and related issues such as obtaining/opposing patents and remedies International intellectual property issues

H.R. 1902, Protecting Consumer Access to Generic Drugs Act of 2007: patent settlements H.R. 1908, Patent Reform Act of 2007: patent issues H.R. 4279, Prioritizing Resources and Organization for Intellectual Property Act of 2007: enforcement S. 316, Preserve Access to Affordable Generics Act: patent settlements S. 522, Intellectual Property Rights Enforcement Act: anti-counterfeiting and enforcement S. 1145, Patent Reform Act of 2007: patent issues S.2317, Intellectual Property Enforcement Act of 2007: enforcement S.3325, Prioritizing Resources and Organization for Intellectual Property Act of 2008: enforcement S.3600, Patent Reform Act of 2008: patent reform and related issues International intellectual property issues

H.R. 380, Pharmaceutical Market Access and Drug Safety Act of 2007: importation H.R. 1038, Access to Life-Saving Medicine Act: follow-on biologics H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007: follow-on biologics H.R. 3610, Food and Drug Import Safety Act of 2007: import safety H.R. 5629, Pathway for Biosimilars Act: follow-on biologics H.R. 5839, Safeguarding America's Pharmaceuticals Act of 2008: anti-counterfeiting H.R. 6151, Responsibility in Drug and Device Advertising Act of 2008: Direct-to-consumer drug advertising H.R. 6381, Medical Device Safety Act of 2008: preemption issues H.R. 6820, Water Assessment and Treatment Evaluation Research Study Act of 2008: pharmaceuticals in drinking water and human health S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007: importation S. 334, Healthy Americans Act: non-interference S. 623, Access to Life-Saving Medicine Act: follow-on biologics S. 1693, Wired for Health Care Quality Act: health information technology and health care quality and costs S. 1695, Biologics Price Competition and Innovation Act of 2007: follow-on biologics S. 2663, CPSC Reform Act: importation S. 3046, Access, Compassion, Care, and Ethics for Seriously Ill Patients Act (ACCESS Act): access to investigational drugs and related issues S. 3398, Medical Device Safety Act of 2008: preemption issues S. 3409, Drug and Device Accountability Act of 2008: import safety S. 3560, QI Program Supplemental Funding Act of 2008: antibiotic exclusivity provisions S. 3633, Transparency in Drug Labeling Act: country of origin labeling for drugs

S. Con Res 21, Senate Budget Resolution, FDA & Medicare Issues H. Con Res 99, House Budget Resolution, FDA & Medicare Issues

S. Con Res 21, Senate Budget Resolution, FDA & Medicare Issues H. Con Res 99, House Budget Resolution, FDA & Medicare Issues

S. 1145, Patent Reform Act of 2007, patent issues HR 1908, Patent Reform Act of 2007, patent issues S. 316, Preserve Access to Affordable Generics Act, patent settlements International Intellectual Property Issues

S. 1145, Patent Reform Act of 2007, patent issues HR 1908, Patent Reform Act of 2007, patent issues S. 316, Preserve Access to Affordable Generics Act, patent settlements International Intellectual Property Issues

S. 1082, Food and Drug Administration Revitalizaton Act of 2007 (Importation, Follow-on Biologics, Patent settlements, Drug Safety and PDUFA) HR. 2900, Food and Drug Administration Amendments Act of 2007 (Drug Safety and PDUFA) S. 1693, Wired for Health Care Quality Act of 2007

HR. 2900, Food and Drug Administration Amendments Act of 2007 (Drug Safety and PDUFA) S. 1693, Wired for Health Care Quality Act of 2007 H.R. 3610, Food and Drug Import Safety Act of 2007 (Importation) H.R. 380, Pharmaceutical Market Access and Drug Safety Act of 2007

HR. 2900, Food and Drug Administration Amendments Act of 2007 (Drug Safety and PDUFA) S. 1693, Wired for Health Care Quality Act of 2007 H.R. 3610, Food and Drug Import Safety Act of 2007 (Importation) H.R. 380, Pharmaceutical Market Access and Drug Safety Act of 2007

HR. 2900, Food and Drug Administration Amendments Act of 2007 (Drug Safety and PDUFA) S. 1693, Wired for Health Care Quality Act of 2007 H.R. 3610, Food and Drug Import Safety Act of 2007 (Importation) H.R. 380, Pharmaceutical Market Access and Drug Safety Act of 2007

HR 4, Medicare Prescription Drug Price Negotiation Act of 2007, Part D Benefit S. 3, Medicare Prescription Drug Price Negotiation Act of 2007, Part D Benefit

HR 4 Medicare Prescription Drug Price Negotiation Act of 2007, Part D Benefit S. 3 Medicare Prescription Drug Price Negotiation Act of 2007, Part D Benefit

S. 1145, Patent Reform Act of 2007, patent issues HR 1908, Patent Reform Act of 2007, patent issues S. 316, Preserve Access to Affordable Generics Act, patent settlements International Intellectual Property Issues

S. 1145, Patent Reform Act of 2007, patent issues HR 1908, Patent Reform Act of 2007, patent issues S. 316, Preserve Access to Affordable Generics Act, patent settlements International Intellectual Property Issues

S. 1082, Food and Drug Administration Revitalizaton Act of 2007 (Importation, Follow-on Biologics, Patent settlements, Drug Safety and PDUFA) HR. 2900, Food and Drug Administration Amendments Act of 2007 (Drug Safety and PDUFA) S. 1693, Wired for Health Care Quality Act of 2007

HR. 2900, Food and Drug Administration Amendments Act of 2007 (Drug Safety and PDUFA) S. 1693, Wired for Health Care Quality Act of 2007 H.R. 3610, Food and Drug Import Safety Act of 2007 (Importation) H.R. 380, Pharmaceutical Market Access and Drug Safety Act of 2007

HR 4 Medicare Prescription Drug Price Negotiation Act of 2007, Part D Benefit S. 3 Medicare Prescription Drug Price Negotiation Act of 2007, Part D Benefit

HR 4, Medicare Prescription Drug Price Negotiation Act of 2007, Part D Benefit S. 3, Medicare Prescription Drug Price Negotiation Act of 2007, Part D Benefit

S. 1145, Patent Reform Act of 2007, patent issues HR 1908, Patent Reform Act of 2007, patent issues S. 316, Preserve Access to Affordable Generics Act, patent settlements International Intellectual Property Issues

S. 1145, Patent Reform Act of 2007, patent issues HR 1908, Patent Reform Act of 2007, patent issues S. 316, Preserve Access to Affordable Generics Act, patent settlements International Intellectual Property Issues